Author | Nancy Dreyer

Articles

Comparative Effectiveness Research: Coming Soon?

Article

Only time will reveal CER's true definition, and determine the full effects of a CER-based system

Personalized Medicine Meets the Real World

Pharmaceutical Executive

Article

Personalized medicines often come to market without much safety information. Small populations mean less data. Genzyme, for example, received FDA approval for Cerezyme, to treat Gaucher disease, based on a pivotal trial with only 30 patients.